Diagnosis, Care, and Specialist Access for Patients Across India
Adult-onset vitelliform macular disease produces a retinal lesion that can look strikingly similar to childhood Best disease on a quick eye exam, which is why Indian ophthalmologists pay close attention to the age at which it's first detected — typically the 30s to 60s in this adult form, compared to childhood for Best disease. Getting this distinction right matters for setting realistic expectations with the patient.
In India, this condition is increasingly picked up incidentally during routine eye exams in middle-aged patients, particularly as OCT imaging becomes more widely available even outside the largest metro hospitals, meaning more cases are being identified before significant vision changes occur.
Many Indian patients with adult-onset vitelliform macular disease have mild or no symptoms at all, with the lesion discovered during an unrelated eye exam — for cataract evaluation, for instance, which remains an extremely common reason Indian adults visit an ophthalmologist. When symptoms occur, they typically involve mild central blur or distortion rather than the more dramatic multi-stage changes seen in childhood Best disease.
The genetics are less uniform than in childhood Best disease — some Indian cases involve the same BEST1 gene, others involve PRPH2, and a meaningful proportion have no clearly identified genetic cause on current testing. Because it often appears without an obvious family history, Indian patients are sometimes surprised to learn it may still have a genetic basis.
OCT and fundus autofluorescence identify the lesion, both now widely accessible across India's retina centres. Electrooculography, typically markedly abnormal in childhood Best disease, is often normal or only mildly reduced here — a key test Indian specialists use to distinguish the two conditions. Genetic testing for BEST1 or PRPH2 can be pursued where family history or diagnostic uncertainty warrants it.
Most Indian cases are managed with observation alone, since the condition frequently remains stable for years. If abnormal blood vessel growth develops — an uncommon complication — anti-VEGF injection therapy, widely available across Indian retina centres, is the standard approach. Regular monitoring, typically annual, helps catch this complication early if it occurs.
Adult-onset vitelliform macular disease appears later in life, tends to be milder, and often shows a normal or near-normal electrooculogram — a test that's typically abnormal in the childhood form.
Yes, it's not unusual for the lesion to be discovered incidentally during a comprehensive eye exam done for cataract assessment, since OCT imaging is now a routine part of many such evaluations.
Not necessarily — many Indian cases occur without any known family history of the condition, which can be part of what distinguishes it from the childhood form.
Usually not — most cases are simply monitored at intervals, with active treatment (anti-VEGF injections) reserved for the uncommon complication of abnormal blood vessel growth beneath the retina.